REQUEST A DEMO
Total
USD $0.00
Search more companies

Pivotal Clinical Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Engineering Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Other Personal and Household Goods Repair and Maintenance
Full name: Pivotal Clinical Sp. z o.o. Profile Updated: February 08, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Pivotal Clinical Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on January 30, 2017. There was a total growth of 50.44% in Pivotal Clinical Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Prosta 67
Warsaw; Mazowieckie; Postal Code: 00-838

Contact Details: Purchase the Pivotal Clinical Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Pivotal Clinical Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Pivotal Clinical Sp. z o.o. report to view the information.
Incorporation Date:
January 30, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pivotal Clinical Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
50.44%
Total Equity
43.23%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?